Mehmeti et al. proved that TLR4 was expressed in a functional form in oestrogen receptor (ER)/progesterone receptor (PR)-negative breast cancers, and a gene expression analysis of primary breast cancers showed a strong correlation between TLR4 expression and the expression of pro-inflammatory mediators [83]. Here, TLR4 is linked to breast carcinoma.